IL307638A - Transgenic rodents expressing horse-rodent chimeric antibodies and methods of using them - Google Patents
Transgenic rodents expressing horse-rodent chimeric antibodies and methods of using themInfo
- Publication number
- IL307638A IL307638A IL307638A IL30763823A IL307638A IL 307638 A IL307638 A IL 307638A IL 307638 A IL307638 A IL 307638A IL 30763823 A IL30763823 A IL 30763823A IL 307638 A IL307638 A IL 307638A
- Authority
- IL
- Israel
- Prior art keywords
- equine
- methods
- rodent antibodies
- expressing chimeric
- transgenic rodents
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/46—Hybrid immunoglobulins
- C07K16/461—Igs containing Ig-regions, -domains or -residues form different species
- C07K16/462—Igs containing a variable region (Fv) from one specie and a constant region (Fc) from another
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/07—Animals genetically altered by homologous recombination
- A01K2217/072—Animals genetically altered by homologous recombination maintaining or altering function, i.e. knock in
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A01K2227/105—Murine
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/01—Animal expressing industrially exogenous proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
- C12N2015/8518—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic expressing industrially exogenous proteins, e.g. for pharmaceutical use, human insulin, blood factors, immunoglobulins, pseudoparticles
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Animal Husbandry (AREA)
- Biodiversity & Conservation Biology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163184440P | 2021-05-05 | 2021-05-05 | |
| PCT/US2022/027622 WO2022235759A1 (en) | 2021-05-05 | 2022-05-04 | Transgenic rodents expressing chimeric equine-rodent antibodies and methods of use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL307638A true IL307638A (en) | 2023-12-01 |
Family
ID=81750504
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL307638A IL307638A (en) | 2021-05-05 | 2022-05-04 | Transgenic rodents expressing horse-rodent chimeric antibodies and methods of using them |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240215556A1 (https=) |
| EP (1) | EP4333613A1 (https=) |
| JP (1) | JP2024516996A (https=) |
| KR (1) | KR20240004503A (https=) |
| CN (1) | CN117440753A (https=) |
| AU (1) | AU2022268937A1 (https=) |
| CA (1) | CA3216988A1 (https=) |
| IL (1) | IL307638A (https=) |
| WO (1) | WO2022235759A1 (https=) |
Family Cites Families (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1293460C (en) | 1985-10-07 | 1991-12-24 | Brian Lee Sauer | Site-specific recombination of dna in yeast |
| GB8823869D0 (en) | 1988-10-12 | 1988-11-16 | Medical Res Council | Production of antibodies |
| US5175384A (en) | 1988-12-05 | 1992-12-29 | Genpharm International | Transgenic mice depleted in mature t-cells and methods for making transgenic mice |
| GB8904009D0 (en) | 1989-02-22 | 1989-04-05 | Celltech Ltd | Vector |
| US5464764A (en) | 1989-08-22 | 1995-11-07 | University Of Utah Research Foundation | Positive-negative selection methods and vectors |
| US6689610B1 (en) | 1989-08-22 | 2004-02-10 | University Of Utah Research Foundation | Cells and non-human organisms containing predetermined genomic modifications and positive-negative selection methods and vectors for making same |
| US6673986B1 (en) | 1990-01-12 | 2004-01-06 | Abgenix, Inc. | Generation of xenogeneic antibodies |
| US5814318A (en) | 1990-08-29 | 1998-09-29 | Genpharm International Inc. | Transgenic non-human animals for producing heterologous antibodies |
| US7041871B1 (en) | 1995-10-10 | 2006-05-09 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
| ATE352612T1 (de) | 1990-08-29 | 2007-02-15 | Pharming Intellectual Pty Bv | Homologe rekombination in säugetier-zellen |
| US5789650A (en) | 1990-08-29 | 1998-08-04 | Genpharm International, Inc. | Transgenic non-human animals for producing heterologous antibodies |
| US5661016A (en) | 1990-08-29 | 1997-08-26 | Genpharm International Inc. | Transgenic non-human animals capable of producing heterologous antibodies of various isotypes |
| US5877397A (en) | 1990-08-29 | 1999-03-02 | Genpharm International Inc. | Transgenic non-human animals capable of producing heterologous antibodies of various isotypes |
| US5874299A (en) | 1990-08-29 | 1999-02-23 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
| WO1992015694A1 (en) | 1991-03-08 | 1992-09-17 | The Salk Institute For Biological Studies | Flp-mediated gene modification in mammalian cells, and compositions and cells useful therefor |
| DE4228162C1 (de) | 1992-08-25 | 1994-01-13 | Rajewsky Klaus Dr | Verfahren zum Ersetzen homologer Genabschnitte aus Säugern in der Keimbahn von nicht-menschlichen Säugern |
| US5593598A (en) | 1994-04-20 | 1997-01-14 | Mcginness; Michael P. | Method and apparatus for closed loop recycling of contaminated cleaning solution |
| US6091001A (en) | 1995-03-29 | 2000-07-18 | Abgenix, Inc. | Production of antibodies using Cre-mediated site-specific recombination |
| US6130364A (en) | 1995-03-29 | 2000-10-10 | Abgenix, Inc. | Production of antibodies using Cre-mediated site-specific recombination |
| EP1500329B1 (en) | 1996-12-03 | 2012-03-21 | Amgen Fremont Inc. | Human antibodies that specifically bind human TNF alpha |
| US6774279B2 (en) | 1997-05-30 | 2004-08-10 | Carnegie Institution Of Washington | Use of FLP recombinase in mice |
| FR2814642B1 (fr) | 2000-10-03 | 2005-07-01 | Ass Pour Le Dev De La Rech En | Souris transgenique pour la recombinaison ciblee mediee par la cre-er modifiee |
| US6596541B2 (en) | 2000-10-31 | 2003-07-22 | Regeneron Pharmaceuticals, Inc. | Methods of modifying eukaryotic cells |
| US7422889B2 (en) | 2004-10-29 | 2008-09-09 | Stowers Institute For Medical Research | Dre recombinase and recombinase systems employing Dre recombinase |
| ATE536374T1 (de) * | 2006-09-01 | 2011-12-15 | Therapeutic Human Polyclonals Inc | Erhöhte expression von humanem oder humanisiertem immunglobulin bei nicht-humanen transgenen tieren |
| JP6482757B2 (ja) * | 2010-07-26 | 2019-03-13 | トリアンニ インコーポレイテッドＴｒｉａｎｎｉ，Ｉｎｃ． | トランスジェニック動物および使用方法 |
| GB2528811A (en) * | 2011-05-06 | 2016-02-03 | Nvip Pty Ltd | Anti-nerve growth factor antibodies and methods of preparing and using the same |
| US20170058052A1 (en) | 2015-08-24 | 2017-03-02 | Trianni, Inc. | Enhanced production of immunoglobulins |
| GB2561352B (en) * | 2017-04-10 | 2023-01-18 | Genome Res Ltd | Animal models and therapeutic molecules |
| GB2578867A (en) * | 2018-10-09 | 2020-06-03 | Genome Res Ltd | Animal models and therapeutic molecules |
| CA3144956A1 (en) * | 2019-07-01 | 2021-01-07 | Trianni, Inc. | Transgenic mammals and methods of use |
| WO2021003152A1 (en) * | 2019-07-01 | 2021-01-07 | Trianni, Inc. | Transgenic mammals and methods of use thereof |
-
2022
- 2022-05-04 AU AU2022268937A patent/AU2022268937A1/en active Pending
- 2022-05-04 IL IL307638A patent/IL307638A/en unknown
- 2022-05-04 CA CA3216988A patent/CA3216988A1/en active Pending
- 2022-05-04 JP JP2023567910A patent/JP2024516996A/ja active Pending
- 2022-05-04 KR KR1020237038920A patent/KR20240004503A/ko active Pending
- 2022-05-04 CN CN202280033146.9A patent/CN117440753A/zh active Pending
- 2022-05-04 EP EP22725093.3A patent/EP4333613A1/en active Pending
- 2022-05-04 WO PCT/US2022/027622 patent/WO2022235759A1/en not_active Ceased
- 2022-05-04 US US18/557,414 patent/US20240215556A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| KR20240004503A (ko) | 2024-01-11 |
| US20240215556A1 (en) | 2024-07-04 |
| WO2022235759A1 (en) | 2022-11-10 |
| CN117440753A (zh) | 2024-01-23 |
| EP4333613A1 (en) | 2024-03-13 |
| AU2022268937A1 (en) | 2023-10-26 |
| CA3216988A1 (en) | 2022-11-10 |
| JP2024516996A (ja) | 2024-04-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL286641A (en) | Engineered iga antibodies and methods of use | |
| SG11202100208VA (en) | Fusion constructs and methods of using thereof | |
| GB2626698B (en) | Engineered chimeric fusion protein compositions and methods of use thereof | |
| IL288457A (en) | Humanized anti-human CD19 antibodies and methods of use | |
| IL275070A (en) | FCRN antibodies and methods of using them | |
| EP3579877A4 (en) | CHEMERIC T-LYMPHOCYTE ANTIGENIC RECEPTORS AND METHODS OF USE | |
| RS67825B1 (sr) | Himerni antigenski receptori zasnovani na jednodomenskim antitelima i postupci njihove upotrebe | |
| EP3402494A4 (en) | CHIMERIC PROTEINS AND METHOD FOR IMMUNOTHERAPY | |
| SG10201912489QA (en) | Chimeric antigen and t cell receptors and methods of use | |
| EP4276185A3 (en) | Rodents comprising a humanized ttr locus and methods of use | |
| SG10201400716PA (en) | Non-human transgenic animals expressing humanised antibodies and use therof | |
| GB2570060B (en) | Experimental device and experimental method for studying quantitative relationship between spawning of parent fish and stimulation of flow velocity | |
| DK3993623T3 (da) | Transgene gnavere og fremgangsmåder til anvendelse deraf | |
| ZA202005982B (en) | Insecticidal proteins from plants and methods for their use | |
| EP3289869A4 (en) | TRANSGENIC NICHTHUMAN ANIMAL FOR EXPRESSION OF HUMAN SPECIMEN MOLECULES AND HUMAN FC UPSILON RECEPTOR FAMILY | |
| SG11202107762QA (en) | Aflibercept attributes and methods of characterizing and modifying thereof | |
| IL280238B2 (en) | Chimeric receptors for STEAP1 and methods of using them | |
| ZA202005981B (en) | Insecticidal proteins from plants and methods for their use | |
| IL279305A (en) | Method and device for crop cultivation | |
| EP4334346A4 (en) | Chimeric receptors and methods of using them | |
| IL307638A (en) | Transgenic rodents expressing horse-rodent chimeric antibodies and methods of using them | |
| IL281767A (en) | CD137-directed antibodies and methods of using them | |
| SG11202104518WA (en) | Pharmaceutical combination of anti ceacam6 and tim3 antibodies | |
| EP3876989A4 (en) | Anti-cfae antibodies and methods of use | |
| EP4249502A3 (en) | Rodents expressing humanized c1q complex |